Mark Murcko | Massachusetts Institute of Technology (MIT) (original) (raw)
Papers by Mark Murcko
Journal of Medicinal Chemistry, 1996
Journal of Computational Chemistry, Dec 1, 1987
Journal of Medicinal Chemistry, Oct 12, 2004
Small molecule protein kinase inhibitors are widely employed as biological reagents and as leads ... more Small molecule protein kinase inhibitors are widely employed as biological reagents and as leads in the design of drugs for a variety of diseases. One of the hardest challenges in kinase inhibitor design is achieving target selectivity. By utilizing X-ray structural information for four promiscuous inhibitors, we propose a five-point pharmacophore for kinase frequent hitters, demonstrate its ability to discriminate between frequent hitters and selective ligands, and suggest a strategy for selective inhibitor design.
The Journal of Physical Chemistry, Jun 1, 1987
ABSTRACT The rotational barrier about the C-C bond of 1,2-dichloroethane has been calculated by u... more ABSTRACT The rotational barrier about the C-C bond of 1,2-dichloroethane has been calculated by using several basis sets (4-31G, 6-31G*, 6-31+G*, and 6-31++G**) and including electron correlation. Corrections for zero-point energy differences, and the differences in enthalpy change from 0 to 298 K, were made by using the calculated geometries and vibrational frequencies. The trans/gauche energy difference was found to be 1.39 kcal/mol as compared to the observed value, 1.1 +/- 0.1 kcal/mol. The intramolecular interactions in the several rotamers are discussed. The trans/gauche energy difference for 1,2-difluoroethane also was calculated (MP3/6-311++G**) and was found to be 0.76 kcal/mol favoring the gauche conformer, again in good agreement with the experimental value of 0.57 +/- 0.09 kcal/mol. The trend in trans/gauche energy differences in the series n-butane, 1,2-dichloroethane, 1,2-difluoroethane is noted.
Journal of the American Chemical Society, Jun 1, 1989
... The Anomeric Effect Revisited Kenneth B. Wiberg* and Mark A. Murckot Contribution from the De... more ... The Anomeric Effect Revisited Kenneth B. Wiberg* and Mark A. Murckot Contribution from the Department of Chemistry, Yale University, New Haven, Connecticut 0651 1. Receiued October 21, 1988 ... Sci. 1960, 44, 266. (21) Noerskov-Lauritsen, L.; Allinger, NL J . Comput. Chem. ...
Journal of Virology, Jul 1, 1997
Chemischer Informationsdienst, Feb 4, 1986
ChemInform, Jun 18, 2010
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was e... more ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Bioorganic & Medicinal Chemistry Letters, Jun 1, 2007
Journal of Computer-aided Molecular Design, Feb 1, 1993
A novel method, which we call GenStar, has been developed to suggest chemically reasonable struct... more A novel method, which we call GenStar, has been developed to suggest chemically reasonable structures which fill the active sites of enzymes. The proposed molecules provide good steric contact with the enzyme and exist in low-energy conformations. These structures are composed entirely of sp3 carbons which are grown sequentially, but which can also branch or form rings. User-selected enzyme seed atoms may be used to determine the area in which structure generation begins. Alternatively, GenStar may begin with a predocked 'inhibitor core' from which atoms are grown. For each new atom generated by the program, several hundred candidate positions representing a range of reasonable bond lengths, bond angles, and torsion angles are considered. Each of these candidates is scored, based on a simple enzyme contact model. The selected position is chosen at random from among the highest scoring cases. Duplicate structures may be removed using a variety of criteria. The compounds may be energy minimized and displayed using standard modeling programs. Also, it is possible to analyze the collection of all structures created by GenStar and locate binding motifs for common fragments such as benzene and naphthylene. Tests of the method using HIV protease, FK506 binding protein (FKBP-12) and human carbonic anhydrase (HCA-II) demonstrated that structures similar to known potent inhibitors may be generated with GenStar.
ChemInform, Aug 3, 2010
ABSTRACT ChemInform is a weekly Abstracting Service, delivering concise information at a glance t... more ABSTRACT ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Journal of the American Chemical Society, 1988
Protein Engineering Design & Selection, 1996
Journal of the American Chemical Society, Oct 1, 1985
Journal of the Chemical Society, 1998
ABSTRACT
Bioorganic & Medicinal Chemistry Letters, Apr 1, 2004
Journal of Medicinal Chemistry, Jun 1, 1993
Journal of Medicinal Chemistry, Dec 1, 1989
Journal of Medicinal Chemistry, Dec 1, 1999
We continue our study of the common features present in drug molecules by looking in detail at dr... more We continue our study of the common features present in drug molecules by looking in detail at drug side chains. Using shape description methods, we divide a database of commercially available drugs into a list of common drug side chains. On the basis of the atom pair shape descriptor (taking into account atom type, hybridization, and bond order), there are 1,246 different side chains among the 5,090 compounds analyzed. The average number of side chains per molecule is 4, and the average number of heavy atoms per side chain is 2. If we ignore the carbonyl side chain, then there are approximately 15,000 occurrences of side chains. Of these 15,000 approximately 11,000 are from the "top 20" group of side chains. This suggests that the diversity that side chains provide to drug molecules is quite low. We discuss ways that this work could be used to provide guidance for molecular design efforts.
Journal of Medicinal Chemistry, 1996
Journal of Computational Chemistry, Dec 1, 1987
Journal of Medicinal Chemistry, Oct 12, 2004
Small molecule protein kinase inhibitors are widely employed as biological reagents and as leads ... more Small molecule protein kinase inhibitors are widely employed as biological reagents and as leads in the design of drugs for a variety of diseases. One of the hardest challenges in kinase inhibitor design is achieving target selectivity. By utilizing X-ray structural information for four promiscuous inhibitors, we propose a five-point pharmacophore for kinase frequent hitters, demonstrate its ability to discriminate between frequent hitters and selective ligands, and suggest a strategy for selective inhibitor design.
The Journal of Physical Chemistry, Jun 1, 1987
ABSTRACT The rotational barrier about the C-C bond of 1,2-dichloroethane has been calculated by u... more ABSTRACT The rotational barrier about the C-C bond of 1,2-dichloroethane has been calculated by using several basis sets (4-31G, 6-31G*, 6-31+G*, and 6-31++G**) and including electron correlation. Corrections for zero-point energy differences, and the differences in enthalpy change from 0 to 298 K, were made by using the calculated geometries and vibrational frequencies. The trans/gauche energy difference was found to be 1.39 kcal/mol as compared to the observed value, 1.1 +/- 0.1 kcal/mol. The intramolecular interactions in the several rotamers are discussed. The trans/gauche energy difference for 1,2-difluoroethane also was calculated (MP3/6-311++G**) and was found to be 0.76 kcal/mol favoring the gauche conformer, again in good agreement with the experimental value of 0.57 +/- 0.09 kcal/mol. The trend in trans/gauche energy differences in the series n-butane, 1,2-dichloroethane, 1,2-difluoroethane is noted.
Journal of the American Chemical Society, Jun 1, 1989
... The Anomeric Effect Revisited Kenneth B. Wiberg* and Mark A. Murckot Contribution from the De... more ... The Anomeric Effect Revisited Kenneth B. Wiberg* and Mark A. Murckot Contribution from the Department of Chemistry, Yale University, New Haven, Connecticut 0651 1. Receiued October 21, 1988 ... Sci. 1960, 44, 266. (21) Noerskov-Lauritsen, L.; Allinger, NL J . Comput. Chem. ...
Journal of Virology, Jul 1, 1997
Chemischer Informationsdienst, Feb 4, 1986
ChemInform, Jun 18, 2010
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was e... more ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Bioorganic & Medicinal Chemistry Letters, Jun 1, 2007
Journal of Computer-aided Molecular Design, Feb 1, 1993
A novel method, which we call GenStar, has been developed to suggest chemically reasonable struct... more A novel method, which we call GenStar, has been developed to suggest chemically reasonable structures which fill the active sites of enzymes. The proposed molecules provide good steric contact with the enzyme and exist in low-energy conformations. These structures are composed entirely of sp3 carbons which are grown sequentially, but which can also branch or form rings. User-selected enzyme seed atoms may be used to determine the area in which structure generation begins. Alternatively, GenStar may begin with a predocked 'inhibitor core' from which atoms are grown. For each new atom generated by the program, several hundred candidate positions representing a range of reasonable bond lengths, bond angles, and torsion angles are considered. Each of these candidates is scored, based on a simple enzyme contact model. The selected position is chosen at random from among the highest scoring cases. Duplicate structures may be removed using a variety of criteria. The compounds may be energy minimized and displayed using standard modeling programs. Also, it is possible to analyze the collection of all structures created by GenStar and locate binding motifs for common fragments such as benzene and naphthylene. Tests of the method using HIV protease, FK506 binding protein (FKBP-12) and human carbonic anhydrase (HCA-II) demonstrated that structures similar to known potent inhibitors may be generated with GenStar.
ChemInform, Aug 3, 2010
ABSTRACT ChemInform is a weekly Abstracting Service, delivering concise information at a glance t... more ABSTRACT ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Journal of the American Chemical Society, 1988
Protein Engineering Design & Selection, 1996
Journal of the American Chemical Society, Oct 1, 1985
Journal of the Chemical Society, 1998
ABSTRACT
Bioorganic & Medicinal Chemistry Letters, Apr 1, 2004
Journal of Medicinal Chemistry, Jun 1, 1993
Journal of Medicinal Chemistry, Dec 1, 1989
Journal of Medicinal Chemistry, Dec 1, 1999
We continue our study of the common features present in drug molecules by looking in detail at dr... more We continue our study of the common features present in drug molecules by looking in detail at drug side chains. Using shape description methods, we divide a database of commercially available drugs into a list of common drug side chains. On the basis of the atom pair shape descriptor (taking into account atom type, hybridization, and bond order), there are 1,246 different side chains among the 5,090 compounds analyzed. The average number of side chains per molecule is 4, and the average number of heavy atoms per side chain is 2. If we ignore the carbonyl side chain, then there are approximately 15,000 occurrences of side chains. Of these 15,000 approximately 11,000 are from the "top 20" group of side chains. This suggests that the diversity that side chains provide to drug molecules is quite low. We discuss ways that this work could be used to provide guidance for molecular design efforts.